| Attribute |
Value |
| 52 Week Change |
-0.6666666 |
| Address1 |
10,900 NE 4th Street |
| Address2 |
Suite 2300 |
| All Time High |
13.4 |
| All Time Low |
0.075 |
| Ask |
0.22 |
| Ask Size |
5,000 |
| Average Daily Volume10 Day |
109,930 |
| Average Daily Volume3 Month |
9,549,493 |
| Average Volume |
9,549,493 |
| Average Volume10Days |
109,930 |
| Beta |
0.482 |
| Bid |
0.1611 |
| Bid Size |
2,500 |
| Book Value |
2.969 |
| City |
Bellevue |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.21 |
| Current Ratio |
0.182 |
| Custom Price Alert Confidence |
LOW |
| Date Short Interest |
1,786,665,600 |
| Day High |
0.21 |
| Day Low |
0.188 |
| Debt To Equity |
4.373 |
| Display Name |
OSR Health |
| Dividend Yield |
0.0 |
| Ebitda |
-7,419,085 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-4.264 |
| Enterprise To Revenue |
17.491 |
| Enterprise Value |
31,636,950 |
| Eps Trailing Twelve Months |
-0.37 |
| Esg Populated |
0 |
| Exchange |
PNK |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.26354 |
| Fifty Day Average Change |
-0.053540006 |
| Fifty Day Average Change Percent |
-0.20315704 |
| Fifty Two Week Change Percent |
-66.666664 |
| Fifty Two Week High |
0.908 |
| Fifty Two Week High Change |
-0.698 |
| Fifty Two Week High Change Percent |
-0.7687225 |
| Fifty Two Week Low |
0.075 |
| Fifty Two Week Low Change |
0.13499999 |
| Fifty Two Week Low Change Percent |
1.7999998 |
| Fifty Two Week Range |
0.075 - 0.908 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,679,405,400,000 |
| Float Shares |
13,167,402 |
| Free Cashflow |
-2,679,485 |
| Full Exchange Name |
OTC Markets OTCPK |
| Full Time Employees |
22 |
| Fullday Change |
0.1165 |
| Fullday Change Percent |
0.0 |
| Fullday Price |
0.21 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.33396998 |
| Gross Profits |
604,060 |
| Has Pre Post Market Data |
0 |
| Held Percent Insiders |
0.44699 |
| Held Percent Institutions |
0.00987 |
| Implied Shares Outstanding |
35,118,692 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington. |
| Long Name |
OSR Health, Inc. |
| Market |
us_market |
| Market Cap |
7,374,925 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_1847710486 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-14 |
| Net Income To Common |
-10,729,865 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
8,600,567 |
| Number Of Analyst Opinions |
1 |
| Open |
0.188 |
| Operating Cashflow |
-7,203,837 |
| Operating Margins |
-9.6079 |
| Payout Ratio |
0.0 |
| Phone |
425 635 7700 |
| Prev Name |
OSR Holdings, Inc. |
| Previous Close |
0.2 |
| Price Hint |
4 |
| Price To Book |
0.07073088 |
| Price To Sales Trailing12 Months |
4.077376 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.111 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.00999999 |
| Regular Market Change Percent |
4.999995 |
| Regular Market Day High |
0.21 |
| Regular Market Day Low |
0.188 |
| Regular Market Day Range |
0.188 - 0.21 |
| Regular Market Open |
0.188 |
| Regular Market Previous Close |
0.2 |
| Regular Market Price |
0.21 |
| Regular Market Time |
1,792,007,532 |
| Regular Market Volume |
39,270 |
| Return On Assets |
-0.059970003 |
| Return On Equity |
-0.11294 |
| Revenue Growth |
-0.722 |
| Revenue Per Share |
0.064 |
| Sand P52 Week Change |
0.1570785 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
35,118,692 |
| Shares Percent Shares Out |
0.0348 |
| Shares Short |
1,222,239 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
1,693,343 |
| Short Name |
OSR Health, Inc. |
| Short Percent Of Float |
0.0911 |
| Short Ratio |
1.44 |
| Source Interval |
15 |
| State |
WA |
| Symbol |
OSRH |
| Target High Price |
10.0 |
| Target Low Price |
10.0 |
| Target Mean Price |
10.0 |
| Target Median Price |
10.0 |
| Total Cash |
1,499,603 |
| Total Cash Per Share |
0.043 |
| Total Debt |
5,462,785 |
| Total Revenue |
1,808,743 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.37 |
| Trailing Peg Ratio |
None |
| Triggerable |
0 |
| Two Hundred Day Average |
0.44347 |
| Two Hundred Day Average Change |
-0.23347001 |
| Two Hundred Day Average Change Percent |
-0.5264618 |
| Type Disp |
Equity |
| Volume |
39,270 |
| Website |
https://osr-holdings.com |
| Zip |
98,004 |